Crosstalk & Modulation or Purigenic, Endocannabinoid, Stem Cell & Immune Signaling

Judy Mikovits, PhD

Presenter

Conference 2018

TRACK

1h0m

Duration

English

Language

Share This Class:

Facebook
Twitter
LinkedIn

Overview

ABOUT THE PRESENTER​

Judy Mikovits, PhD

Dr. Judy Mikovits earned a BA in Chemistry from University of Virginia in 1980 and a Ph.D. in Biochemistry and Molecular Biology from George Washington University in 1992. In her forty-year quest to understand the causes, prevent and treat chronic diseases, she has co-authored seminal papers culminating in at least a decade of research in each of four fields: immunology, natural products chemistry, epigenetics, and HIV/AIDs drug development. In 2009 Dr. Mikovits led the team that first isolated and characterized a new family of human disease-associated retroviruses, XMRVs/HGRVS. Dr. Mikovits has co-authored more than 50 peer-reviewed publications and book chapters; holds patent # WO 2012061790 A1. “Combination Therapy for Prostate Cancer using Botanical Compositions and Bicalutamide”.

Dr Mikovits is a New York Times Bestselling author of the books, PlaguePlague of Corruption, and the Case Against the Masks and Ending Plague.

Her current focus is on medical cannabis with breakthroughs in understanding of the pathophysiology of neuroimmune diseases as acquiredendocannabinoid im- mune dysfunction (AEIDS) including COVID-19.

RESEARCH MATERIAL

Login